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Background: Whilst it is well known that psychosocial determinants may contribute to cardiovascular diseases
(CVD), data from specific groups are scarce. The present study aims to determine the contribution of psychosocial
determinants in increasing the risk of cardiovascular events (myocardial infarction and stroke), and death from CVD,
in a high risk adult population.
Methods: Longitudinal prospective study of 7263 patients (57.5% women), mean age 67.0 (SD 6.2) free from CVD
but at high risk, with a median follow-up of 4.8 years (from October 2003 to December 2010). The Hazard Ratios
(HRs) of cardiovascular events (myocardial infarction, stroke, and death from cardiovascular causes) related to
educational attainment, diagnosed depression (based on medical records), and low social support (number of
people living in the household) were estimated by multivariate Cox regression models.
Results: Stroke incidence was associated with low educational level in the whole population (HR: 1.83, 95% CI:
1.09–3.09), and especially in men (HR: 2.11, 95% CI 1.09–4.06). Myocardial infarction and CVD mortality were not
associated with any of the psychosocial factors considered.
Conclusion: Adults with low educational level had a higher risk of stroke. Depression and low social support were
not associated with CVD incidence.
Trial registration: Clinical trial registration information unique identifier: ISRCTN35739639.
Keywords: Stroke, Acute myocardial infarction, Cardiovascular death, Educational level, Socioeconomic position,
Depression, Social support, Health inequalitiesBackground
Cardiovascular disease (CVD) remains the leading cause
of mortality worldwide, and in most developed countries
is the major origin of disability among elderly people. In
2008, heart attacks and strokes were responsible for 7.3
and 6.2 million deaths, respectively [1]. Its incidence has
been strongly related with classic risk factors (hyperten-
sion, dyslipidemia, and type 2 diabetes), and poor life-
styles (smoking, physical inactivity, and unhealthy diet)* Correspondence: mamunoz.bcn.ics@gencat.cat
1Department of Paediatrics, Obstetrics, Gynaecology and Preventive
Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain
21Institut Català de la Salut, Barcelona, Spain
Full list of author information is available at the end of the article
© 2014 Mejía-Lancheros et al.; licensee BioMe
Creative Commons Attribution License (http:/
distribution, and reproduction in any medium
Domain Dedication waiver (http://creativecom
article, unless otherwise stated.[2,3]. In recent decades, inadequate psychosocial and liv-
ing conditions have also been found to be linked to CVD
[4,5]. Individual conditions such as low socioeconomic
status, weak social support, depression, and residing in
disadvantaged neighborhoods may contribute to socioeco-
nomic inequalities in cardiovascular health [4-9]. Their
roles, however, are not yet entirely clear [8,9] and, in some
contexts, not taken into consideration. In Spain, where so-
cioeconomic health disparity is not as pronounced as in
some other European countries [10], and CVD incidence
is one of the lowest in the world [1,11,12], there are few
studies which have evaluated the effect of psycho-social
factors [13].d Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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The present study aimed at determining whether adverse
psychosocial conditions such as lower educational level,
depression, and weak social support contribute to in-
creasing the risk of cardiovascular events (myocardial in-
farction and stroke) and death from CVD in an adult
population at high cardiovascular risk.
Methods
Study design and population
This is a longitudinal, prospective study embedded within
the PREDIMED Study (Prevention with Mediterranean
diet) carried out from October 2003 to December 2010, in
Spain. Details of PREDIMED study enrollment, design,
population, methods, and main results have been described
elsewhere [14]. For the purpose of this article, we analyzed
7263 participants (women and men) aged 55–80 years old,
at high cardiovascular risk, but free from cardiovascular
disease at baseline (97.5% of PREDIMED participants),
with complete, available data concerning psychosocial risk
factors.
Inclusion criteria
participants had to have at least one of the following
two conditions: a) Medical diagnosis of type 2 diabetes
or receiving insulin or oral hypoglycemic drugs; or
having fasting glucose >126 mg/dl or presented casual
glucose >200 mg/dl with polyuria, polydipsia, or unex-
plained weight loss; or glucose > 200 mg/dl in two mea-
surements after an oral glucose tolerance test. b) At
least three of the following risk factors: smoking (>1
cig/day during the last month); hypertension (systolic
blood pressure > =140 mm Hg or diastolic blood pres-
sure > =90 mmHg or under antihypertensive medica-
tion); elevated low-density lipoprotein cholesterol levels
(> = 160 mg/dl); low high-density lipoprotein cholesterol
levels (<= 40 mg/dl); overweight (body mass index > =
25 kg/m2); or a family history of premature coronary heart
disease (CHD) (definite myocardial infarction or sudden
death before 55 years in father or male 1st-degree relative,
or before 65 years in mother or female 1st-degree relative).
If the HDL-cholesterol level was > =60 mg/dL, one risk fac-
tor was subtracted.
Exclusion criteria
Participants with any of the following were excluded: docu-
mented history of previous cardiovascular disease or severe
medical conditions (digestive disease with fat intolerance,
advanced malignancy, major neurological, psychiatric or
endocrine disease); immunodeficiency; illegal drug use;
problematic alcohol intake (chronic alcoholism or total
daily alcohol intake >80 g/d); body mass index > 40 kg/m2;
difficulties or major inconvenience to change dietary
habits; impossibility of following a Mediterranean-typediet or understanding the recommendations of the proto-
col; and lack of autonomy.
Data were collected from medical records, clinical evalua-
tions, and face to face interviews. Validated questionnaires
were administered in order to obtain information on nutri-
tional habits [15,16]. Blood samples for laboratory tests were
gathered. All participants gave written informed consent.
The study was approved by the Institutional Review Board
of Hospital Clinic (Barcelona, Spain), and registered in
the Current Controlled Trials (number: ISRCTN35739639,
http://www.controlled-trials.com/ISRCTN35739639).
Study variables
Psychosocial conditions
Educational level: Educational level was used as a proxy of
socioeconomic position (SP) since it is considered a strong
determinant of social status that may condition employ-
ment and income opportunities [17]. For the purpose of
the study, educational attainment in the bivariate analysis
was classified into three groups: high education (secondary
or university studies), primary education (completed pri-
mary school), and less than primary education. In the
multivariate analysis, educational level was divided into
two groups: high education (secondary or university stud-
ies) and low education (up to primary school).
Social support: Social support in the household was
considered to be low when participants were living
alone. Living alone has been reported as a valid proxy to
evaluate social support, and has been found to be an in-
dependent social risk factor for adverse cardiovascular
event outcome [18].
Depression: Information regarding history of diagnosis
of depression was self-reported by participants during a
face to face interview at the inclusion visit and further
confirmed in clinical records. In Spain, the diagnosis of
depression is carried out by both psychiatrists and GPs
following the American Psychological Association clin-
ical criteria (DSM-IV) or other mental health scales (e.g.
the Beck Depression Inventory).
Other co-variables: socio-demographic variables: Age
(years) and gender. Smoking status: Never smoked, former
smoker, and current smoker. Alcohol intake: High alcohol
consumption (Alcohol consumption more than 20 gr. daily
in men and 10 gr. daily in women). Body mass index
(BMI): Expressed as weight in kilograms divided by height
in meters squared (Kg/m2). Cardiovascular risk factors:
Hypertension (Medical diagnosis of hypertension or re-
ceiving at least one of the following antihypertensive drugs:
angiotensin-converting-enzyme inhibitor (ACE inhibitors),
diuretics, calcium channel blockers, angiotensin II recep-
tor antagonists, ß-blockers, α-blockers, or other antihy-
pertensive drugs); Diabetes (medical diagnosis of Type 2
diabetes or receiving insulin and/or oral hypoglycemic
drugs); Dyslipidemia (medical diagnosis of dyslipidemia or
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ture coronary heart disease (CHD). Mediterranean dietary
intervention: (i) Low fat Mediterranean diet (control diet):
dietary recommendation which highlighted the consump-
tion of lean meats, low-fat dairy products, cereals, pota-
toes, pasta, rice, fruit and vegetables. The use of olive oil
for cooking and dressing and consumption of nuts, fatty
meats, sausages, and fatty fish were discouraged. (ii) Medi-
terranean diet enriched with extra-virgin olive oil (EVOO):
positive dietary recommendation about the Mediterranean
diet pattern emphasizing the abundant use of olive oil for
cooking and dressing dishes. One liter per week of EVOO
was supplied to the participants in this group. (iii) Medi-
terranean diet enriched with mixed nuts: positive dietary
recommendation about the Mediterranean diet pattern
with the addition of nuts. Participants received 30 g of
mixed nuts per day (15 g of walnuts, 7.5 g of almonds and
7.5 g hazelnuts).
The PREDIMED study dietitians supervised the dietary
intervention. Further details about PREDIMED study
dietary intervention has been previously published [14].
End points
Composite primary cardiovascular event
The primary end point was a composite variable made
up of the first occurrence of cardiovascular death, or
myocardial infarction, or stroke (combining ischemic and
hemorrhagic). Diagnostic criteria are available in a supple-
mentary appendix of a previously published article [14].
The three cardiovascular events were also considered
separately in the analysis in order to individually ascer-
tain the impact of psychosocial factors.
Cardiovascular events were reviewed and confirmed
by an Adjudication Committee of the PREDIMED Study
consisting of a team of cardiologists, endocrinologists,
neurologists, and ophthalmologists. Members of the
committee were blinded to the intervention and dietary
habits of the participants; for an event to be accepted a
consensus was required. Events that had occurred be-
tween October 1st, 2003 and December 1st, 2010 were
analyzed. Transient Ischemic Attack was not considered
as a stroke. All end points were ascertained by regular
contacts with participants and/or families, annual revi-
sions of medical records, data from GPs, and consult-
ation of the National Death Index (Spain).
Statistical analyses
Bivariate analysis was performed using chi-square test for
analyzing differences among proportions, and t-student or
one-way ANOVA for differences among means. Crude
Rate/1000 person-year (95% confidence interval: CI) of
cardiovascular events was calculated. Crude and adjusted
Hazard ratios (HR) with 95% CI were performed by Cox
regression models for the analysis of time-dependentcardiovascular events in relation to psychosocial factors.
Multivariate Cox models were adjusted for age, gender,
smoking, alcohol consumption, BMI hypertension, type 2
diabetes, dyslipidemia, family history of premature CVD
at baseline, and the randomized arm of the Mediterranean
dietary intervention during the trial. To assess whether
cardiovascular events could be predicted by unfavorable
psychosocial factors related to gender, all multivariate ad-
justed analysis were stratified by sex. The proportional HR
assumption from the multivariate Cox models was vali-
dated with time-varying tests (Schoenfeld residuals ap-
proach) [19]. The global test p-values were ≥ 0.05.
Participants were considered censored when no event
was registered during the study or data had been lost dur-
ing follow-up. Censoring was assumed to be independent
of the main study variables and non-informative. The
resulting bias was, however, minimized by our close partici-
pant follow-up.
On the other hand our study was right censoring because
some events had not occurred when the study ended.
Individuals lacking information concerning their psy-
chosocial risk factors were not included. As this repre-
sented an insubstantial percentage (2.5%), their exclusion
was not expected to greatly affect the internal and external
validity of the observed results.
Results
Main baseline characteristics of study participants
The mean age of participants was 67.0 years (SD 6.2), and
57.5% were women. Regarding psychosocial factors, 74.8%
of the participants had only attained primary education and
2.5% had less than primary school, 18.0% had a previous
diagnostic of depression, and 10.0% weak social support
(living alone in the household). With respect to cardiovas-
cular risk factors, 14.0% (n = 1020) of the participants were
currently smokers, 91.1% (n = 6620) had hypertension,
72.1% (n = 5238) diabetes, 77.8% (n = 5648) dyslipidemia,
and 22.2% (n = 1615) reported family history of coronary
heart disease.
Characteristics of the population regarding psychosocial
factors
Participants with primary and less than primary education
were more frequently older, women, and overweight. They
had low social support and a higher percentage of type 2
diabetes and depression. In contrast, they consumed less
alcohol and were less frequently smokers. Participants
with weak social support were more commonly older,
women, with dyslipidemia, depression and low education,
but they were less frequently smokers. Depression was as-
sociated with women, overweight, dyslipidemia, family his-
tory of coronary heart disease, weak social support, and a
low educational level, however, they consumed less alcohol
and tobacco (Table 1).
Table 1 Characteristics of participants according to psychosocial factors at baseline
Education level Social support in the household Diagnosis of depression
High
education*
Primary
education
Less than primary
education
Live with
other
Live alone None Yes
(N = 1646) (N = 5433) (N = 184) (N = 6535) (N = 728) (N = 5954) (N = 1309)
(%) (%) (%) p-value (%) (%) p-value (%) (%) p-value
Age (mean; SD†) 64.6 (6.2) 67.7 (6.1) 69.4 (5.0) <0.001 66.6 (6.1) 70.1 (6.2) <0.001 67.0 (6.3) 66.8 (6.0) 0.217
Sex (Women) 37.4 62.6 89.7 <0.001 54.8 82.1 <0.001 52.7 79.8 0.001
Type of
Mediterranean
diet
Low fat diet 29.0 34.0 26.1 0.453 32.4 34.9 0.130 32.2 34.4 0.096
With extra-
Virgin Olive oil
33.8 34.2 42.4 34.7 31.0 34.2 35.1
With mixed
nuts
37.2 31.8 31.0 32.9 34.1 33.6 30.6
High alcohol
consumption‡
30.0 18.8 8.2 <0.001 21.5 17.1 0.007 22.5 14.6 <0.001
Smoking status
Never smoked 41.4 66.5 84.8 <0.001 59.9 73.9 <0.001 58.4 74.5 <0.001
Former smoker 36.9 21.5 9.2 25.5 17.0 27.1 13.5
Current-smoker 21.7 12.0 6.8 14.6 9.1 14.5 12.0
Body-mass index
(Kg/m2)
29.3 (3.7) 30.1 (3.8) 30.7 (4.1) <0.001 30.0 (3.8) 30.0 (4.2) 0.743 29.9 (3.8) 30.5 (4.0) <0.001
Cardiovascular risk
factors§
Hypertension 90.5 91.2 94.6 0.159 91.0 92.6 0.151 91.1 91.4 0.756
Type 2 diabetes 67.7 73.2 81.0 <0.001 72.1 72.1 0.998 72.1 72.3 0.840
Dyslipidemia 77.5 77.8 79.9 0.764 77.4 81.2 0.019 77.2 80.5 0.008
Family history
of premature
CHD¶
23.7 21.9 20.1 0.231 22.4 21.0 0.404 21.6 25.1 0.007
Living alone 8.3 10.5 12.5 0.022 —— ————— ———— 9.0 14.7 <0.001
Diagnostic of
depression
15.2 18.6 27.7 <0.001 17.1 26.5 <0.001 ———— ——— ——
Educational level
High
education*
— ——— —— 23.1 18.8 0.022 23.4 19.1 <0.001
Primary
education
— ——— —— 74.4 78.0 74.3 77.0
Less than
primary
education
— ——— —— 2.5 3.2 2.2 3.9
*High education means university studies or secondary school.
†Standard deviation.
‡Alcohol consumption presented 68 missing values in its denominator. Standard deviation.
§Hypertension (Medical diagnosis of hypertension or taking antihypertensive treatment), Type 2 diabetes (Medical diagnosis of diabetes or taking antidiabetic
treatment) and Dyslipidemia (Medical diagnosis of dyslipidemia or taking lowering-lipid therapy).
¶CHD denotes coronary heart disease.
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quartile range 2.8 to 5.8). In our sample 280 CVD
events occurred. Participants with a high educational
level had 56 events (7.9 per 1000 person-year) versus
224 (9.2 per 1000 person-year) in those with a loweducational one. Participants with higher social support
had 257 CVD events (9.1 per 1000 person-year) versus
23 (7.5 per 1000 person-year) in those living alone. A
total of 248 (9.6 per 1000 person-year) CVD events oc-
curred in people without depression versus 32 (5.7 per
Table 2 Incidence and adjusted hazard ratios for cardiovascular events according to psychosocial factors
Educational level* Social support in the household Diagnosis of depression
High education Low education Live with other Live alone No Yes
(N = 1646) (N = 5617) (N = 6535) (N = 728) (N = 5954) (N = 1309)
Person-year of follow-up 7069,0 24280,89 28287,36 3062,56 25751,12 5598,79
Composite primary cardiovascular event
Number of events 56 224 257 23 248 32
Crude Rate/1000 person-year (95% CI) 7.9 (5.8–10.0) 9.2 (8.0–10.4) 9.1 (8.0–10.2) 7.5 (4.4–10.6) 9.6 (8.4–10.8) 5.7 (3.7–7.7)
Adjusted Hazard Ratio (95% CI)†‡ 1.00 (ref) 1.16 (0.85–1.57) 1.00 (ref) 0.85 (0.54–1.32) 1.00 (ref) 0.76 (0.52–1.11)
p-value 0.351 0.458 0.155
Myocardial Infarction
Number of events 24 79 95 8 90 13
Crude Rate/1000 person-year (95% CI) 3.4 (2.0–4.8) 3.3 (2.5–4.0) 3.4 (2.7–4.0) 2.6 (0.8–4.4) 3.5 (2.8–4.2) 2.3 (1.1–3.6)
Adjusted Hazard Ratio (95% CI)†‡ 1.00 (ref) 1.10 (0.69–1.78) 1.00 (ref) 1.01 (0.48–2.12) 1.00 (ref) 0.89 (0.49–1.62)
p-value 0.686 0.980 0.699
Stroke
Number of events 17 119 127 9 121 15
Crude Rate/1000 person-year (95% CI) 2.4 (1.3–3.5) 4.9 (4.0–5.8) 4.5 (3.7–5.3) 2.9 (1.0–4.9) 4.7 (3.9–5.5) 2.7 (1.3–4.0)
Adjusted Hazard Ratio (95% CI)†‡ 1.00 (ref) 1.83 (1.09–3.09) 1.00 (ref) 0.56 (0.28–1.12) 1.00 (ref) 0.66 (0.38–1.15)
p-value 0.023 0.102 0.145
Cardiovascular Death
Number of events 25 58 73 10 73 10
Crude Rate/1000 person-year (95% CI) 3.5 (2.2–4.9) 2.4 (1.8–3.0) 2.6 (2.0–3.2) 3.3 (1.2–5.3) 2.8 (2.2–3.5) 1.8 (0.7–2.9)
Adjusted Hazard Ratio (95% CI)†‡ 1.00 (ref) 0.63 (0.38–1.03) 1.00 (ref) 1.21 (0.60–2.46) 1.00 (ref) 0.93 (0.47–1.84)
p-value 0.064 0.598 0.832
*High education means university studies or secondary school; Low education: up to primary studies.
†Multivariable models were adjusted by: age, gender, smoking, alcohol consumption, body-mass index, hypertension, type 2 diabetes, dyslipidemia and family
history of premature coronary heart disease, and type Mediterranean diet intervention.
‡Test of proportional-hazard assumption (p-value based on the scaled Schoenfeld residuals): Composite primary cardiovascular event model (specific p-value for
Educational level: 0.529, Social support: 0.765 and Depression: 0.877); Myocardial infarction model (0.611, 0.717 and 0.914); Stroke model (p-values = 0.204, 0.598
and 0.411); Cardiovascular death model (p-values = 0.810, 0.831 and 0.129).
Figure 1 Survival function of stroke adjusted according education
level based on Cox proportional hazard model. The Cox model was
adjusted by Sex, age, smoking, alcohol consumption, body mass index,
hypertension, type 2 diabetes, dyslipidemia, family history of premature
cardiovascular disease, and type of Mediterranean diet intervention. High
education means university education or secondary school, and low
education denotes primary education.
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educational level was associated with an increased risk of
stroke (adjusted Hazard Ratio (HR): 1.83, 95% CI: 1.09–
3.09) (Table 2, Figure 1). The risk of stroke was higher in
men (Adjusted HR: 2.11, 95% CI: 1.09–4.06) than in
women (adjusted HR: 1.46, 95% CI: 0.62–3.43) (Table 3).
A Mediterranean diet with EVOO or nuts showed a
protective combined cardiovascular effect. Current and
former smokers had a higher risk of suffering cardiovas-
cular events. Hypertensive individuals tended to have a
greater risk of experiencing a cardiovascular event. Dia-
betics presented more risk of stroke (statistical signifi-
cance at the limit point: p-value: 0.052). No higher risk
for participants with dyslipidemia and family history of
premature CHD was found (Table 4).
Discussion
In our study it was observed that an adult population at
high cardiovascular risk, with low education level, had
an increased risk of stroke.
Table 3 Adjusted hazard ratios for cardiovascular events according to psychosocial factors stratified by gender
Composite primary
cardiovascular event
Myocardial infarction Stroke Cardiovascular death
Adjusted HR
(95% CI)†‡
p-value Adjusted HR
(95% CI)†‡
p-value Adjusted HR
(95% CI)†‡
p-value Adjusted HR
(95% CI)†‡
p-value
Men
Educational level*
High education 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Low education 1.25 (0.87–1.80) 0.223 1.34 (0.76–2.35) 0.308 2.11 (1.09–4.06) 0.026 0.65 (0.36–1.16) 0.148
Social support in the household
Live with others 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Live alone 0.74 (0.30–1.61) 0.512 0.74 (0.18–3.05) 0.682 0.33 (0.46–2.39) 0.272 1.53 (0.47–4.98) 0.477
Diagnosis of Depression
No 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Yes 0.76 (0.40–1.46) 0.414 0.50 (0.16–1.60) 0.241 0.56 (0.17–1.79) 0.327 1.42 (0.56–3.62) 0.460
Women
Educational level*
High education 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Low education 0.97 (0.56–1.70) 0.922 0.63 (0.27–1.50) 0.295 1.46 (0.62–3.43) 0.383 0.56 (0.22–1.39) 0.211
Social support in the household
Live with others 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Live alone 0.81 (0.48–1.37) 0.437 1.12 (0.45–2.79) 0.810 0.54 (0.25–1.16) 0.114 1.04 (0.43–2.54) 0.926
Diagnosis of Depression
No 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Yes 0.76 (0.48–1.22) 0.256 1.19 (0.57–2.48) 0.650 0.71 (0.38–1.33) 0.281 0.71 (0.27–1.88) 0.495
*High education means university studies or secondary school; Low education: up to primary studies.
†Multivariable models were adjusted by: age, smoking, alcohol consumption, body-mass index, hypertension, type 2 diabetes, dyslipidemia and family history of
premature coronary heart disease, and type Mediterranean diet intervention.
‡Global test of proportional-hazard assumption (p-value based on the scaled Schoenfeld residuals) men: Composite primary cardiovascular event model (0.172);
Myocardial infarction model (0.723); Stroke model (0.260); Cardiovascular death model (0.369); women: Global test of proportional-hazard assumption (p-value
based on the scaled Schoenfeld residuals) women: Composite primary cardiovascular event model (0.553); Myocardial infarction model (0.320); Stroke model
(0.870); Cardiovascular death model (0.458).
Mejía-Lancheros et al. BMC Cardiovascular Disorders 2014, 14:135 Page 6 of 9
http://www.biomedcentral.com/1471-2261/14/135Educational level was employed as a measure to evalu-
ate socioeconomic position (SP) because it tends to re-
main stable throughout life. It is strongly related to the
possibility of greater social and material opportunities by
influencing future employment and income, and the
adoption of healthy lifestyles [17]. As a proxy of SP, edu-
cational level has been widely used in a number of car-
diovascular research studies [8,20,21].
Although, in general, Spain has one of the lowest inci-
dences of cardiovascular diseases, our results linking so-
cioeconomic level and stroke concur with findings from
other studies performed in Anglo-Saxon and Scandinavian
countries [21-23].
Classic stroke risk factors and harmful lifestyles are
likely to be more prevalent among socioeconomically de-
prived groups [6,22]. In some studies, the socioeconomic
gradient observed in the relationship between SP and
stroke was partially mediated by traditional risk and psy-
chological factors [24,25]. In our population, however,
the association between stroke and educational level wasindependent of the cardiovascular risk factor profile and
unhealthy lifestyle, as has previously been observed [26].
CVD mortality is decling in Spain yet we observed a
high prevalence of poor management of traditional risk
factors, and a low rate of proper treatment for the popu-
lation at risk. Findings that are in agreement with studies
carried out on the population attended by the Health
System in Catalunya, a region in Spain [27,28].
Strong primary healthcare models play a key role in re-
ducing socioeconomic health inequalities [29]. The Spanish
system, for instance is both free and universal with GPs
acting as gatekeepers to specialist care. Yet we are of the
opinion that, in contrast to other countries where health
expenditure has been found to be inversely associated with
stroke incidence [30,31], inequality regarding accessibility
to health services had a negligible effect on CVD incidence
in our population. Indeed, in a previous study we found no
differences in the preventive treatment received according
to educational level which could justify social inequalities
in the incidence of CVD [32].
Table 4 Adjusted hazard ratios for cardiovascular outcomes within all covariables include in the final multivariable models
Composite primary
cardiovascular event
Myocardial infarction Stroke Cardiovascular death
HR (95% CI)†‡ p-value HR (95% CI)†‡ p-value HR (95% CI)†‡ p-value HR (95% CI)†‡ p-value
Age (years) 1.08 (1.06–1.10) <0.001 1.04 (1.00–1.07) 0.034 1.09 (1.05–1.12) <0.001 1.15 (1.11–1.19) <0.001
Type of Mediterranean diet
With extra-Virgin Olive oil 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
With mixed nuts 0.97 (0.74–1.35) 0.984 0.98 (0.60–1.60) 0.938 0.76 (0.49–1.22) 0.277 1.37 (0.80–2.34) 0.255
Low fat diet 1.42 (1.07–1.88) 0.014 1.35 (0.84–2.15) 0.205 1.44 (0.98–2.12) 0.062 1.38 (0.80–2.38) 0.242
High alcohol consumption 0.85 (0.63–1.15) 0.292 0.59 (0.35–1.00) 0.052 1.17 (0.77–1.77) 0.472 0.98 (0.58–1.66) 0.949
Smoking status
Never smoked 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Former smoker 1.45 (1–04–2.03) 0.031 1.47 (0.84–2.56) 0.176 1.14 (0.69–1.86) 0.615 2.27 (1.22- 4.24) 0.010
Current-smoker 1.94 (1–33–2.84) 0.001 2.18 (1.20–3.97) 0.011 1.46 (0.82–2.58) 0.197 2.51 (1.20–5.22) 0.014
Body-mass index (Kg/m2) 1.01 (0.97–1.04) 0.661 1.01 (0.96–1.07) 0.697 1.00 (0.95–1.04) 0.875 1.03 (0.96–1.09) 0.421
Hypertension 1.79 (1.06–3.02) 0.030 1.53 (0.70–3.32) 0.284 2.19 (0.96–4.99) 0.063 2.22 (0.69–7.08) 0.179
Type 2 diabetes 1.30 (0.98–1.74) 0.071 1.23 (0.78–1.96) 0.374 1.53 (1.00–2.35) 0.052 1.21 (0.71–2.05) 0.477
Dyslipidaemia 0.91 (0.70–1.18) 0.468 0.82 (0.54–1.26) 0.376 0.94 (0.64–1.38) 0.762 0.89 (0.55–1.44) 0.630
Family history of premature CHD§ 1.24 (0.92–1.68) 0.155 1.56 (0.98–2.48) 0.060 1.25 (0.82–1.91) 0.304 0.70 (0.34–1.40) 0.313
†All Hazard Ratios are adjusted by sex and psychosocial factors (educational level, depression and social support in the household).
‡Global test of proportional-hazard assumption (p-value based on the scaled Schoenfeld residuals): Composite primary cardiovascular event model (0.471);
Myocardial infarction model (0.758); Stroke model (0.303); Cardiovascular death model (0.107).
§CHD denotes coronary heart disease.
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http://www.biomedcentral.com/1471-2261/14/135The fact that the other psychosocial factors considered,
such as depression and low social support, were not found
to be related to CVD remains to be elucidated. Through
the understanding of social disparities in stroke it would
be possible to more effectively address social and clinical
actions for cardiovascular prevention in the most disad-
vantaged social groups.
The Spanish population tends to use the health system
quite often, as a result, the probability of being treated
for comorbid conditions such as depression is high and
the effect of this condition on stroke incidence could be
reduced by proper treatment. The number of people liv-
ing alone among our participants was low. It is possible
that a longer follow-up or a larger sample might demon-
strate some relationship between living alone and CVD
incidence. It should also be taken into account that in
the Mediterranean countries, families still play an im-
portant role in the care of elderly people; therefore, the
effect of living alone could be lower than in other
countries.
Strengths and limitations
Unfortunately, no other socioeconomic indicators were
available to carry out a sensitivity analysis. Educational
level has, however, been found to be a reliable indication
of socioeconomic position [17]. With respect to evaluating
the effect of social support on cardiovascular outcomes,
we took into consideration the number of people living inthe home as household size has proven to be a valid proxy
[18]. We were, therefore, unable to assess this effect on
institutionalized patients or those lacking autonomy. More-
over, since history of depression was self-reported it is
possible that the real proportion of depressive patients
was under-registered.
Although there are peculiarities in the pathogenesis of
hemorrhagic and ischemic stroke, their prevention and
management are quite similar, and previous studies have
found a relationship between low SP, measured by a
deprivation index, for both types. We could not differen-
tiate between hemorrhagic and ischemic stroke because
we only had aggregated data [33]. It could be useful in
the future to carry out studies to demonstrate whether
differences between ischemic and hemorrhagic stroke
are due to socioeconomic status.
We are aware that, since several end points have been
considered in the analysis and, multiple comparisons
among different subgroups of participants may increase
type I error. Nevertheless, since our study specifically
tested the relationship between psychosocial determi-
nants and cardiovascular events we did not carry out
multiple analyses other than those needed to answer the
main question.
Conclusions
In a population at high cardiovascular risk, the incidence
of stroke was higher in those with lower educational
Mejía-Lancheros et al. BMC Cardiovascular Disorders 2014, 14:135 Page 8 of 9
http://www.biomedcentral.com/1471-2261/14/135level. History of depression and low social support were
not associated with CVD incidence.
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